GenMark Diagnostics PE Ratio 2010-2019 | GNMK

Current and historical p/e ratio for GenMark Diagnostics (GNMK) from 2010 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. GenMark Diagnostics PE ratio as of January 23, 2020 is 0.00.
GenMark Diagnostics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-01-23 5.14 0.00
2019-09-30 6.06 $-0.85 0.00
2019-06-30 6.49 $-0.85 0.00
2019-03-31 7.09 $-0.92 0.00
2018-12-31 4.86 $-0.92 0.00
2018-09-30 7.35 $-0.97 0.00
2018-06-30 6.38 $-1.05 0.00
2018-03-31 5.44 $-1.12 0.00
2017-12-31 4.17 $-1.21 0.00
2017-09-30 9.63 $-1.22 0.00
2017-06-30 11.83 $-1.21 0.00
2017-03-31 12.82 $-1.14 0.00
2016-12-31 12.24 $-1.14 0.00
2016-09-30 11.80 $-1.08 0.00
2016-06-30 8.70 $-1.08 0.00
2016-03-31 5.27 $-1.07 0.00
2015-12-31 7.76 $-1.01 0.00
2015-09-30 7.87 $-1.01 0.00
2015-06-30 9.06 $-0.97 0.00
2015-03-31 12.98 $-0.95 0.00
2014-12-31 13.61 $-0.92 0.00
2014-09-30 8.97 $-0.97 0.00
2014-06-30 13.53 $-1.04 0.00
2014-03-31 9.94 $-1.02 0.00
2013-12-31 13.29 $-0.94 0.00
2013-09-30 12.14 $-0.81 0.00
2013-06-30 10.35 $-0.71 0.00
2013-03-31 12.92 $-0.72 0.00
2012-12-31 9.00 $-0.87 0.00
2012-09-30 9.21 $-1.01 0.00
2012-06-30 4.34 $-1.12 0.00
2012-03-31 4.05 $-1.25 0.00
2011-12-31 4.12 $-1.53 0.00
2011-09-30 5.75 $-1.56 0.00
2011-06-30 5.85 $-1.67 0.00
2011-03-31 3.99 $-1.88 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.297B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $136.357B 28.24
Intuitive Surgical (ISRG) United States $70.528B 55.43
Edwards Lifesciences (EW) United States $50.680B 46.02
IDEXX Laboratories (IDXX) United States $24.673B 59.67
Fresenius Medical Care AG KGaA (FMS) Germany $23.506B 15.91
Olympus (OCPNY) Japan $22.084B 165.85
DexCom (DXCM) United States $21.559B 193.07
Teleflex (TFX) United States $17.886B 36.31
SONOVA HOLDING (SONVY) Switzerland $15.930B 0.00
Sysmex ADR (SSMXY) Japan $15.077B 40.58
Hologic (HOLX) United States $14.544B 22.23
Varian Medical Systems (VAR) United States $13.597B 32.24
STERIS (STE) Ireland $12.954B 28.61
Masimo (MASI) United States $9.124B 54.48
ABIOMED (ABMD) United States $8.328B 45.31
SARTORIUS AG (SARTF) Germany $6.731B 59.08
Penumbra (PEN) United States $5.956B 193.85
Globus Medical (GMED) United States $5.296B 32.68
Integra LifeSciences Holdings (IART) United States $5.015B 21.55
Elekta AB (EKTAY) Sweden $4.611B 38.94
Tandem Diabetes Care (TNDM) United States $4.100B 0.00
Nevro (NVRO) United States $3.867B 0.00
Wright Medical Group (WMGI) Netherlands $3.832B 232.31
LivaNova (LIVN) United Kingdom $3.531B 25.42
Integer Holdings (ITGR) United States $2.976B 20.37
Cantel Medical (CMD) United States $2.894B 28.32
Nihon Kohden (NHNKY) Japan $2.501B 25.17
Glaukos (GKOS) United States $2.110B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.551B 30.52
Veracyte (VCYT) United States $1.393B 0.00
Silk Road Medical (SILK) United States $1.343B 0.00
Mesa Laboratories (MLAB) United States $1.179B 43.69
OPKO Health (OPK) United States $1.151B 0.00
Natus Medical (NTUS) United States $1.147B 27.59
CryoLife (CRY) United States $1.134B 116.31
Tactile Systems Technology (TCMD) United States $1.099B 125.61
Inogen (INGN) United States $1.048B 33.09
Luminex (LMNX) United States $1.018B 0.00
Accelerate Diagnostics (AXDX) United States $0.920B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.874B 29.04
OrthoPediatrics (KIDS) United States $0.802B 0.00
Intersect ENT (XENT) United States $0.793B 0.00
Pacific Biosciences Of California (PACB) United States $0.760B 0.00
Quotient (QTNT) Switzerland $0.662B 0.00
AngioDynamics (ANGO) United States $0.559B 25.60
Si-Bone (SIBN) United States $0.551B 0.00
AxoGen (AXGN) United States $0.511B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.451B 13.63
Alphatec Holdings (ATEC) United States $0.414B 0.00
Sientra (SIEN) United States $0.359B 0.00
Stereotaxis (STXS) United States $0.355B 0.00
Accuray (ARAY) United States $0.352B 0.00
Semler Scientific (SMLR) United States $0.327B 45.46
RTI Surgical (RTIX) United States $0.312B 84.40
SeaSpine Holdings (SPNE) United States $0.309B 0.00
ViewRay (VRAY) United States $0.304B 0.00
Fluidigm (FLDM) United States $0.303B 0.00
IRadimed (IRMD) United States $0.297B 41.66
CRH Medical (CRHM) Canada $0.291B 81.20
Restoration Robotics (VERO) Canada $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.130B 0.00
EDAP TMS S.A (EDAP) France $0.116B 30.69
Electromed (ELMD) United States $0.084B 30.24
Neuronetics (STIM) United States $0.080B 0.00
ConforMIS (CFMS) United States $0.078B 0.00
Vermillion (VRML) United States $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.070B 0.00
Second Sight Medical Products (EYES) United States $0.065B 0.00
Apollo Endosurgery (APEN) United States $0.063B 0.00
Bioanalytical Systems (BASI) United States $0.059B 0.00
T2 Biosystems (TTOO) United States $0.055B 0.00
Helius Medical Technologies (HSDT) United States $0.036B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.035B 0.00
Neovasc (NVCN) Canada $0.033B 0.00
Ekso Bionics Holdings (EKSO) United States $0.029B 0.00
TransEnterix (TRXC) United States $0.028B 0.00
Ra Medical Systems (RMED) United States $0.025B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.024B 0.00
Xtant Medical Holdings (XTNT) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
ENDRA Life Sciences (NDRA) United States $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.015B 21.67
OBALON THERPTCS (OBLN) United States $0.015B 0.00
ReWalk Robotics (RWLK) Israel $0.015B 0.00
Lianluo Smart (LLIT) China $0.014B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Avinger (AVGR) United States $0.012B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Viveve Medical (VIVE) United States $0.002B 0.00